| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.964 | 38.090 | 40.974 | 52.060 | 60.907 | 60.601 | 77.505 | 96.924 | 131.439 | 151.002 |
| Total Income - EUR | 26.988 | 38.134 | 41.073 | 52.096 | 60.915 | 60.601 | 79.526 | 96.923 | 131.439 | 151.002 |
| Total Expenses - EUR | 24.084 | 43.526 | 26.897 | 44.929 | 47.528 | 53.034 | 56.526 | 66.884 | 76.854 | 79.842 |
| Gross Profit/Loss - EUR | 2.904 | -5.392 | 14.176 | 7.166 | 13.387 | 7.567 | 23.000 | 30.040 | 54.585 | 71.160 |
| Net Profit/Loss - EUR | 2.094 | -5.861 | 9.568 | 6.646 | 12.775 | 7.152 | 22.205 | 29.168 | 53.271 | 66.630 |
| Employees | 1 | 0 | 5 | 3 | 4 | 4 | 4 | 4 | 4 | 3 |
Check the financial reports for the company - Nb Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.799 | 97.884 | 90.466 | 102.846 | 96.560 | 86.600 | 75.720 | 65.260 | 58.164 | 53.488 |
| Current Assets | 1.577 | 538 | 326 | 893 | 3.202 | 22.078 | 27.013 | 26.674 | 23.026 | 44.608 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 114 | 34 | 184 | 204 | 102 | 1.808 | 12.558 | 39.418 |
| Cash | 1.577 | 538 | 212 | 859 | 3.017 | 21.874 | 26.911 | 24.866 | 10.468 | 5.190 |
| Shareholders Funds | 4.566 | -1.342 | 8.249 | 14.743 | 27.232 | 33.868 | 48.204 | 55.248 | 79.271 | 92.485 |
| Social Capital | 11.294 | 11.178 | 10.989 | 10.788 | 10.579 | 10.378 | 10.148 | 10.179 | 10.149 | 10.092 |
| Debts | 1.810 | 99.764 | 82.542 | 88.996 | 72.530 | 74.809 | 54.529 | 36.686 | 1.918 | 5.611 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nb Med S.r.l.